Equities Analysts Offer Predictions for CVE:HIV Q2 Earnings

HIVE Blockchain Technologies Ltd. (CVE:HIV) – Equities research analysts at Northland Capmk upped their Q2 2026 earnings estimates for HIVE Blockchain Technologies in a report released on Wednesday, January 29th. Northland Capmk analyst M. Grondahl now expects that the company will post earnings per share of $0.07 for the quarter, up from their previous estimate of $0.01. Northland Capmk also issued estimates for HIVE Blockchain Technologies’ Q4 2026 earnings at $0.15 EPS and FY2026 earnings at $0.28 EPS.

HIVE Blockchain Technologies (CVE:HIV) last announced its earnings results on Tuesday, November 12th. The company reported C($0.08) earnings per share for the quarter, beating the consensus estimate of C($0.12) by C$0.04. During the same quarter in the previous year, the company earned ($0.39) earnings per share.

Several other brokerages also recently issued reports on HIV. Roth Capital raised HIVE Blockchain Technologies to a “strong-buy” rating in a report on Wednesday, December 18th. Cantor Fitzgerald raised HIVE Blockchain Technologies to a “strong-buy” rating in a report on Tuesday, October 29th. Finally, Keefe, Bruyette & Woods raised shares of HIVE Blockchain Technologies to a “moderate buy” rating in a report on Wednesday, January 8th. Four research analysts have rated the stock with a strong buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Strong Buy”.

HIVE Blockchain Technologies Price Performance

HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.